New smart oxygen device aims to free lung patients from constant monitoring

NCT ID NCT07222592

Not yet recruiting Symptom relief Sponsor: National Jewish Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a lightweight, battery-powered device called MoblO2 that automatically adjusts oxygen flow to keep blood oxygen at a healthy level during exercise. It is designed for people with COPD or interstitial lung disease who need supplemental oxygen. Over two weeks, 48 participants will use the device while doing daily activities to see if it improves physical activity, oxygen use, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MoblO2 device (closed-loop oxygen delivery system)
What this could lead to: If it works, this device could make oxygen therapy easier and less burdensome, helping people with lung disease stay active and worry less about their oxygen levels.
What could go wrong: This is a small, early-stage study (48 people) testing a device for two weeks. It may not show clear benefits, and the device could malfunction or be inconvenient in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset interstitial lung disease pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD INTERSTITIAL LUNG DISEASE

Contacts and locations

Locations

Stanford University

Stanford, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.